AUTL
Price
$1.32
Change
-$0.03 (-2.22%)
Updated
May 9 closing price
Capitalization
351.31M
81 days until earnings call
GNTA
Price
$4.34
Change
+$0.12 (+2.84%)
Updated
May 9 closing price
Capitalization
79.38M
Ad is loading...

AUTL vs GNTA

Header iconAUTL vs GNTA Comparison
Open Charts AUTL vs GNTABanner chart's image
Autolus Therapeutics
Price$1.32
Change-$0.03 (-2.22%)
Volume$2.76M
Capitalization351.31M
Genenta Science SpA
Price$4.34
Change+$0.12 (+2.84%)
Volume$794
Capitalization79.38M
AUTL vs GNTA Comparison Chart
Loading...
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AUTL vs. GNTA commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUTL is a StrongBuy and GNTA is a Hold.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (AUTL: $1.32 vs. GNTA: $4.34)
Brand notoriety: AUTL and GNTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AUTL: 143% vs. GNTA: 3%
Market capitalization -- AUTL: $351.31M vs. GNTA: $79.38M
AUTL [@Biotechnology] is valued at $351.31M. GNTA’s [@Biotechnology] market capitalization is $79.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUTL’s FA Score shows that 1 FA rating(s) are green whileGNTA’s FA Score has 0 green FA rating(s).

  • AUTL’s FA Score: 1 green, 4 red.
  • GNTA’s FA Score: 0 green, 5 red.
According to our system of comparison, both AUTL and GNTA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUTL’s TA Score shows that 5 TA indicator(s) are bullish while GNTA’s TA Score has 5 bullish TA indicator(s).

  • AUTL’s TA Score: 5 bullish, 3 bearish.
  • GNTA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both AUTL and GNTA are a good buy in the short-term.

Price Growth

AUTL (@Biotechnology) experienced а -2.22% price change this week, while GNTA (@Biotechnology) price change was +9.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.25%. For the same industry, the average monthly price growth was +9.40%, and the average quarterly price growth was -13.49%.

Reported Earning Dates

AUTL is expected to report earnings on Jul 31, 2025.

GNTA is expected to report earnings on Mar 28, 2025.

Industries' Descriptions

@Biotechnology (-6.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AUTL($351M) has a higher market cap than GNTA($79.4M). GNTA YTD gains are higher at: -0.230 vs. AUTL (-43.830).
AUTLGNTAAUTL / GNTA
Capitalization351M79.4M442%
EBITDA-202.12MN/A-
Gain YTD-43.830-0.23019,066%
P/E RatioN/AN/A-
Revenue10.1MN/A-
Total Cash588MN/A-
Total Debt52.6MN/A-
FUNDAMENTALS RATINGS
AUTL: Fundamental Ratings
AUTL
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AUTLGNTA
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 10 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 10 days ago
69%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 10 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 10 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 10 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 13 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 11 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 10 days ago
90%
View a ticker or compare two or three
Ad is loading...
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA298.2613.44
+4.72%
Tesla
GME27.540.76
+2.84%
GameStop Corp
AAPL198.531.04
+0.53%
Apple
SPY564.34-0.72
-0.13%
SPDR® S&P 500® ETF
BTC.X102970.850000-270.609380
-0.26%
Bitcoin cryptocurrency

AUTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUTL has been loosely correlated with CRSP. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if AUTL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUTL
1D Price
Change %
AUTL100%
-2.22%
CRSP - AUTL
48%
Loosely correlated
-1.44%
NTLA - AUTL
44%
Loosely correlated
-1.93%
RCKT - AUTL
44%
Loosely correlated
-0.71%
OCUL - AUTL
44%
Loosely correlated
-5.23%
SCPH - AUTL
43%
Loosely correlated
-2.79%
More

GNTA and

Correlation & Price change

A.I.dvisor tells us that GNTA and BEIGF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNTA and BEIGF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNTA
1D Price
Change %
GNTA100%
+2.84%
BEIGF - GNTA
28%
Poorly correlated
N/A
ATBPF - GNTA
28%
Poorly correlated
N/A
RLFTF - GNTA
24%
Poorly correlated
-3.52%
AUTL - GNTA
21%
Poorly correlated
-2.22%
ADVM - GNTA
21%
Poorly correlated
-9.94%
More